Cytotoxic effects of adenovirus- and lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase on Bcap37 breast cancer cells

Oncology Reports

Volumn 29, Issue 3, 2013, Pages 960-966

  Zhang, Nianqu ^a   Dong, Xiaoshen ^a   Sun, Yiqun ^b   Cai, Xiaopeng ^a   Zheng, Caiwei ^c   He, Anning ^a   Xu, Ke ^a   Zheng, Xinyu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Benxi Beiying Iron and Steel Group Co Ltd   (China)

^c BRANDEIS UNIVERSITY   (United States)

Author keywords

Adenovirus; Drosophila melanogaster deoxyribonucleoside kinase; Lentivirus; Nucleoside analog; Suicide gene

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; DEOXYRIBONUCLEOSIDE KINASE; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PHOSPHOTRANSFERASE; REPLICATION DEFECTIVE ADENOVIRUS VECTOR; REPLICATION DEFECTIVE LENTIVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL LABELING; CELL PROLIFERATION; CELL STRAIN BCAP37; CONTROLLED STUDY; CYTOMETRY; DROSOPHILA MELANOGASTER; DRUG CYTOTOXICITY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMACYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; BROMODEOXYURIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COMBINED MODALITY THERAPY; DROSOPHILA PROTEINS; FEMALE; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PRODRUGS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84872783345     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2194     Document Type: Article

References (27)

1. Akcay MN: Metastatic disease in the breast. Breast 11: 526-528, 2002. (Pubitemid 35469914)
2. Munch-Petersen B, Piskur J and Sondergaard L: Four deoxy-nucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase. J Biol Chem 273: 3926-3931, 1998. (Pubitemid 28103251)
3. Munch-Petersen B, Knecht W, Lenz C, Sondergaard L and Piskur J: Functional expression of a multisubstrate deoxyri-bonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants. J Biol Chem 275: 6673-6679, 2000. (Pubitemid 30129971)
4. Ito M, Suda Y, Harashima H and Kamiya H: Cytotoxic effect of Drosophila deoxynucleoside kinase gene on replicating plasmid in HeLa cells. Biol Pharm Bull 33: 1223-1227, 2010.
5. Zhu Z, Mao L, Zhao L, et al: Synergistic therapeutic effect in gastric cancer cells produced by oncolytic adenovirus encoding Drosophila melanogaster deoxyribonucleoside kinase. Cancer Biol Ther 11: 874-882, 2011.
6. Ma S, Zhao L, Zhu Z, et al: The multisubstrate deoxyribonucleo-side kinase of Drosophila melanogaster as a therapeutic suicide gene of breast cancer cells. J Gene Med 13: 305-311, 2011.
7. Ma S, Qu W, Mao L, et al: Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer. Oncol Rep 27: 1443-1450, 2012.
8. Zhang N, Zhao L, Ma S, Gu M and Zheng X: Lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleo-side kinase driven by the hTERT promoter combined with gemcitabine: a potential strategy for cancer therapy. Int J Mol Med 30: 659-665, 2012.
9. Kojaoghlanian T, Flomenberg P and Horwitz MS: The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 13: 155-171, 2003. (Pubitemid 36566085)
10. Poller W, Fechner H, Noutsias M, Tschoepe C and Schultheiss HP: Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy. Z Kardiol 91: 978-991, 2002. (Pubitemid 36051102)
11. VandenDriessche T, Collen D and Chuah MK: Viral vector-mediated gene therapy for hemophilia. Curr Gene Ther 1: 301-315, 2001.
12. Sugiyama O, An DS, Kung SP, et al: Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 11: 390-398, 2005. (Pubitemid 40277315)
13. Sandrini MP, Clausen AR, On SL, Aarestrup FM, Munch-Petersen B and Piskur J: Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner. J Antimicrob Chemother 60: 510-520, 2007. (Pubitemid 47299864)
14. Bonini C, Bondanza A, Perna SK, et al: The suicide gene therapy challenge: how to improve a successful gene therapy approach. Mol Ther 15: 1248-1252, 2007. (Pubitemid 46965319)
15. Yazawa K, Fisher WE and Brunicardi FC: Current progress in suicide gene therapy for cancer. World J Surg 26: 783-789, 2002. (Pubitemid 36920318)
16. Bastide C, Maroc N, Bladou F, et al: Expression of a model gene in prostate cancer cells lentivirally transduced in vitro and in vivo. Prostate Cancer Prostatic Dis 6: 228-234, 2003. (Pubitemid 37185151)
17. Johansson M, Brismar S and Karlsson A: Human deoxycytidine kinase is located in the cell nucleus. Proc Natl Acad Sci USA 94: 11941-11945, 1997. (Pubitemid 27467821)
18. Zhu C, Johansson M and Karlsson A: Incorporation of nucleoside analogs into nuclear or mitochondrial DNA is determined by the intracellular phosphorylation site. J Biol Chem 275: 26727-26731, 2000.
19. Knecht W, Sandrini MP, Johansson K, Eklund H, Munch-Petersen B and Piskur J: A few amino acid substitutions can convert deoxyribonucleoside kinase specificity from pyrimidines to purines. EMBO J 21: 1873-1880, 2002. (Pubitemid 34614643)
20. Solaroli N, Bjerke M, Amiri MH, Johansson M and Karlsson A: Active site mutants of Drosophila melanogaster multisubstrate deoxyribonucleoside kinase. Eur J Biochem 270: 2879-2884, 2003. (Pubitemid 36801828)
21. Zhu Z, Ma S, Zhao L, et al: Adenovirus-mediated Drosophila melanogaster deoxyribonucleoside kinase mutants combined with gemcitabine harbor a safe cancer treatment profile. Int J Oncol 38: 745-753, 2011.
22. Knecht W, Mikkelsen NE, Clausen AR, et al: Drosophila mela-nogaster deoxyribonucleoside kinase activates gemcitabine. Biochem Biophys Res Commun 382: 430-433, 2009.
23. Mueller C and Flotte TR: Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 15: 858-863, 2008. (Pubitemid 351712619)
24. Calcedo R, Vandenberghe LH, Gao G, Lin J and Wilson JM: Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis 199: 381-390, 2009.
25. Liu J, Saghizadeh M, Tuli SS, et al: Different tropism of adenovi-ruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Mol Vis 14: 2087-2096, 2008.
26. Sharma A, Tovey JC, Ghosh A and Mohan RR: A AV serotype influences gene transfer in corneal stroma in vivo. Exp Eye Res 91: 440-448, 2010.
27. Donsante A, Miller DG, Li Y, et al: A AV vector integration sites in mouse hepatocellular carcinoma. Science 317: 477, 2007. (Pubitemid 47196106)